17 hours ago Phone: 614-754-5500 Scheduling: 614-754-5600 Billing: 614-457-4220 Our Locations >> Go To The Portal
View medical records, pay a bill, receive alerts about test results, and more. Login anytime, anywhere. Patient Portal | Gastro Health Gastro Health Menu Find a Doctor Find a Doctor Where
Within the New York Bariatric Group patient portal you will find a place to easily track your weight loss progress, request a change of appointments online, email staff members, and purchase diet supplements, foods, and beverages.
We are pleased to announce our new partnership with Gastro Health, a leading national medical group specializing in digestive health. In 2021, we will begin operating under the Gastro Health name. We consider the digestive system to be the soul of the body. The digestive system nourishes the entire body.
We employ a talented team of specialists who perform more GI procedures each year than any other practice in our area. We want your visit to Ohio Gastro to be as easy and comfortable as possible. Our dedication to your care and comfort starts as soon as you enter our office.
We are pleased to announce our new partnership with Gastro Health, a leading national medical group specializing in digestive health. In 2021, we will begin operating under the Gastro Health name.
gPortal is a secure link between you and our practice. It can be used to request an appointment or prescription, check your results, update your personal and medical records, or any other non-emergency communication. To get started, contact our office today!
We consider the digestive system to be the soul of the body. The digestive system nourishes the entire body. Without proper nourishment and metabolism, we don’t have health, healing or energy.
Dr. Shail Govani joined Ohio Gastroenterology Group in 2019. He has been a practicing gastroenterologist since 2014. He earned his medical degree from University of Texas Southwestern in Dallas. He subsequently completed his residency and fellowship at the University of Michigan. Dr. Govani has a special interest in the management of inflammatory bowel disease.
We’ve added 20 new gastroenterologists, previously affiliated with a local hospital, to our team. Click to learn more about our new providers and schedule an appointment.
We are pleased to announce our new partnership with Gastro Health, a leading national medical group specializing in digestive health. In 2021, we will begin operating under the Gastro Health name.
We consider the digestive system to be the soul of the body. The digestive system nourishes the entire body. Without proper nourishment and metabolism, we don’t have health, healing or energy.
The Physicians and Staff of Akron Digestive Disease Consultants are committed to providing outstanding personalized and timely digestive health care to our patients, as we prevent and treat digestive disease. We achieve this through:
Our board-certified gastroenterologists at Cleveland Clinic Akron General have the expertise and advanced technology needed to diagnose and treat all types of digestive conditions.
Gastroenterology is an area of medicine that focuses on your digestive health, often referred to as the gastrointestinal (GI) tract. Chronic heartburn, constipation, abdominal cramps, nausea, gas or diarrhea can all be symptoms of serious conditions within organs that are part of your GI tract. These organs can include your:
Our expert physicians can also perform endoscopic procedures in order to evaluate whether a consultation with a GI surgeron may be necessary and help you find the right type of treatment.
Portal hypertenisive gastropathy (PHG) and GAVE syndrome are recently discovered entities who can be associated with bloodloss from gastrointestinal tract at patients with or without liver cirrhosis. PHG will be developed at 65% of patients with portal hypertension caused by liver cirrhosis but it could be developed at portal hypertension which is not caused by the liver cirrhosis. PHG is often assosiated with portal hypertension patients and presence of esofageal and /or gastric varices. Mechanism of pathogenesis PHG is still not completely cleared up, but regulation of gastric nitric oxide level, postaglandins, tumor necrosis factor (TNF) and epidermal growth factor production could be important factors in development of portal hypertensive gastropathy. Mechanisms who participate in originating of Gastric Antral Vascular Ectasia (GAVE) are also not completly clear. Classic characteristics of this syndrome are red, often haemorrhagic lesions most often located in stomach antrum, and who could result in blood loss. More than 70% of patients with GAVE syndrome have no cirrhosis or portal hypertension. But when liver cirrhosis is present, it is very difficult to make difference between GAVE and PHG. This review will be focused on incidence, clinical importance, etiology, pathofisiology and treatment of PHG, and how to differentiate between GAVE syndrom and PHG in a case that there exists.
The pathophysiology of GAVE is not fully understood. In patients with cirrhosis, portal hypertension appears not to be essential in its development as patients do not respond to portal pressure-reducing therapies, such as TIPS or surgical shunt 40, 62. Liver insufficiency seems to play a significant role in the development of GAVE because it develops in patients with more severe liver dysfunction 59and it has been shown to resolve after liver transplantation 61, 63. Speculation regarding an accumulation of substances not metabolized by the liver which may induce vasodilatation and/or angiogenesis has been suggested as a posible mechanism 62. The association between GAVE and hormones with vasodilating properties such as gastrin 18, 54, 59and prostaglandin E264has also been suggested. Finally abnormal antral motility 65and mechanical stress 18have also been associated to the pathogenesis of GAVE which is further supported by the antral distribution of the lesions.
The prevalence of PHG in patients with portal hypertension has been reported to vary between 20% and 80% 1, 9-12. The wide variation in the reported prevalence is most likely due to differences in the study population specifically, the proportion of patients with non-cirrhotic portal hypertension, the severity of the underlying liver disease, and the proportion of patients with previous endoscopic treatment. A higher rate of PHG is observed in patients with more severe liver disease 10, 11and in patients who have had previous endoscopic treatment with sclerotherapy or endoscopic variceal ligation 1, 9, 12There is controversy regarding the specific endoscopic technique used for variceal eradication that leads to a higher prevalence of PHG, with some studies showing a higher incidence after sclerotherapy than after ligation and other studies showing a similar incidence with both techniques 13-15. Although many studies have concluded that the presence of PHG is associated with indirect signs of portal hypertension such as the presence of larger varices 1, 11, splenomegaly 10, 11and low platelet count 11, the studies that evaluated the association between the hepatic venous pressure gradient, a well established method to measure portal pressure 16, and PHG have lead to controversial results. Two studies found no clear relationship between HVPG and PHG 17, 18, while another study found that patients with more severe gastropathy had a higher HVPG than patients with mild or no gastropathy19. These controversial results may be due to selection bias, as all patients who were included in these studies had clinically significant portal hypertension 17, 18. The issue would be clearer if it could be demonstrated that PHG presents only in patients with cirrhosis and portal hypertension (HVPG ≥ 6mmHg) or only in those with clinically significant portal hypertension (HVPG ≥ 10mmHg). However, such studies are still lacking.
Nonalcoholic Fatty Liver Disease (NAFLD) is the term used for the buildup of extra fat within liver cells in individuals who consume little or no alcohol.
Some studies have evaluated alternative non-endoscopic methods for the diagnosis of PHG 31, 32such as MRI or CT although until further evaluation in larger populations is available, endoscopy still remains the chief diagnostic method. In a study evaluating the efficacy of capsule endoscopy in the evaluation of the presence and size of varices, capsule endoscopy was shown to have only moderate sensitivity and specificity for the detection of PHG 33. Future studies should specifically evaluate its efficacy in evaluating not only the presence but also the severity of PHG as capsule endoscopy will be particularly important in the evaluation of lesions in the small bowel.
The most effective specific treatments in patients with PHG are those aimed at reducing portal pressure. The main pharmacological agent that has been investigated in this setting is the nonselective beta-blocker propranolol.
Classic characteristics of this syndrome are red, often haemorrhagic lesions most often located in stomach antrum, and who could result in blood loss. More than 70% of patients with GAVE syndrome have no cirrhosis or portal hypertension.
Within the New York Bariatric Group patient portal you’ll find a place to easily track your weight loss progress, request change of appointments online, email staff members, and purchase diet supplements, foods and beverages. You can also update detailed profile information which will make visits to our office more efficient and comprehensive. Registering to use the portal takes just a few minutes, and can be completed by clicking here.
The expert bariatric surgeon team at New York Bariatric Group is here to lead you down the path to weight loss success. If you are frustrated with a cycle of small weight loss victories followed by disheartening weight gain, let us show you how we can help. Our team, led by Dr. Shawn Garber, is enthusiastic about educating each patient so you are empowered to make the best decision about your health and obesity treatment options.
Revision bariatric surgery refers to a weight loss treatment that follows a previous weight loss surgery that did not lead to the desired level of success . Learn more. In addition to primary bariatric surgery, our weight loss surgeons are well experienced in revisional procedures. If you are in the New York, Manhattan or New Jersey area, ...
Our weight loss surgeons have performed thousands of gastric sleeve , gastric bypass, lap band, and other bariatric procedures. Our minimally invasive surgeries are not quick fixes for obesity, but are significant tools that allow patients to succeed in losing weight with the appropriate lifestyle changes. Additionally, our surgeries are performed laparoscopically at our bariatric clinic. Laparoscopic procedures generally result in smaller scars, less post-surgical pain, and shorter recovery times.
The gastric sleeve, or sleeve gastrectomy surgery, is a minimally invasive procedure that produces consistently proven results.
The Gastroenterology Group has locations in both Slidell and Covington. Each location contains a medical office for patient exams and an endoscopy center, which is an ambulatory center where our physicians perform procedures.
GGR hosted its first colonoscoparty with a group of four patients coming in to support one another during their colonoscopies. With March being National Colorectal Cancer Awareness Month, it was the perfect time for a colorectal cancer screening. Dr. Bushra Fazili, Dr. Michael Kader, and Dr.... Read Article
If you go to one of the following care centers ( Amberley Village, Anderson, Clermont, Clifton, Fairfield, Harrison, Liberty Township, Montgomery (8231), Montgomery (8271), Norwood, West Side, Westbourne ), please click below.
If you go to one of the following care centers ( Ada, Bluffton, Celina, Delphos, Glandorf, Kalida , Lima, Van Wert ), please call our office at 419-227-8209.